Banks

Hipgnosis Songs Fund, the London-listed investment trust focused on music catalogues, has announced a £150m share placing to fund its backlog of asset acquisitions.

Unédic hit the market on Wednesday with a €2bn 15 year social benchmark, entering the market as the ripples from Tuesday's €20bn Next Generation EU bond print settled.

Canadian Imperial Bank of Commerce managed an outstanding result in sterling covered bonds on Wednesday. Despite the fact that 60% of this year’s entire supply has come in the past three days it managed to issue a sizeable deal at the same spread as an earlier one from Bank of Nova Scotia.

Bank of Cyprus has ended its longstanding absence from the syndicated senior market, returning to print a preferred senior bond that will count towards its minimum requirement for own funds and eligible liabilities (MREL).

Sparebanken Vest this week paired a visit to its home market for additional tier one (AT1) debt with the early redemption of outstanding paper in the format.

Helios Towers, the London-listed telecoms towers company focused on the Middle East and Africa, has completed a $160m capital raising, including a $50m tap of its outstanding 2027 convertible bond.

Property manager Yuexiu Services Group has hit the road with an up to HK$2.41bn ($310.5m) IPO.

Nayuki Holdings, a Chinese teahouse chain, is set to launch its Hong Kong IPO on Friday, according to a source close to the deal.

China Aoyuan Group’s attempt to woo investors to its $200m bond with a generous yield fell flat on Tuesday. Recent concerns about the property developer’s leverage, and the subsequent fall of its dollar bonds in the aftermarket, held investors back from the new deal — and caused a further spiral in secondary. Morgan Davis reports.

VPBank Finance, the consumer finance arm of Vietnam Prosperity Joint Stock Commercial Bank, has returned to the loan market just four months after its last deal. But this time around, it has brought together a diverse mix of lenders to run its fundraising — a rarity for transactions from the country. Pan Yue reports.

Credit Suisse has promoted two veteran bankers in its Greater China private banking business.

Shanghai Junshi Biosciences has raised HK$2.56bn ($330.5m) in equity capital from a placement of shares that drew a solid response from investors both during wall-crossing and bookbuilding.